FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * BURCAR ALISON D   2. Issuer Name and Ticker or Trading Symbol ICU MEDICAL INC/DE [ICUI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) General Mgr, Infusion Systems (Last) (First) (Middle) 951 CALLE AMANECER 3. Date of Earliest Transaction (Month/Day/Year) 12/02/2014 (Street) SAN CLEMENTE, CA 92673 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12/02/2014   X   605 A $ 61.76 2,337 D   Common Stock 12/02/2014   X   2,978 A $ 46.53 5,315 D   Common Stock 12/02/2014   X   2,708 A $ 43.62 8,023 D   Common Stock 12/02/2014   X   2,708 A $ 43.12 10,731 D   Common Stock 12/02/2014   X   938 A $ 37 11,669 D   Common Stock 12/02/2014   X   63 A $ 32.31 11,732 D   Common Stock 12/02/2014   X   10,000 A $ 32.07 21,732 D   Common Stock 12/02/2014   S   18,447 D $ 84.6102 (1) 3,285 D   Common Stock 12/02/2014   S   1,553 D $ 85.1177 (2) 1,732 D   Common Stock 12/02/2014   S(3)   212 D $ 84.667 (4) 1,520 D   Common Stock 12/02/2014   S   748 D $ 84.6208 (5) 772 D   Common Stock 12/02/2014   S   772 D $ 84.6645 (6) 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 32.07

12/02/2014

X

10,000

02/04/2014

02/04/2019

Common Stock

10,000

(7)

0

D

Non-Qualified Stock Option (right to buy)

$ 32.31

12/02/2014

X

63

(8)

02/04/2020

Common Stock

63

(7)

0

D

Non-Qualified Stock Option (right to buy)

$ 37

12/02/2014

X

938

(8)

07/21/2020

Common Stock

938

(7)

0

D

Non-Qualified Stock Option (right to buy)

$ 43.12

12/02/2014

X

2,708

(8)

02/02/2021

Common Stock

2,708

(7)

417

D

Non-Qualified Stock Option (right to buy)

$ 43.62

12/02/2014

X

2,708

(8)

07/20/2021

Common Stock

2,708

(7)

1,667

D

Non-Qualified Stock Option (right to buy)

$ 46.53

12/02/2014

X

2,978

(8)

02/01/2022

Common Stock

2,978

(7)

2,748

D

Non-Qualified Stock Option (right to buy)

$ 61.76

12/02/2014

X

605

(8)

02/06/2023

Common Stock

605

(7)

23,019

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
BURCAR ALISON D 951 CALLE AMANECER SAN CLEMENTE, CA 92673			General Mgr, Infusion Systems

Signatures

By: Lynn Ehrhart For: Alison D. Burcar		12/03/2014
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.06 to $85.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(2)	The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.08 to $85.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(3)	Shares purchased through Employee Stock Purchase Plan.
(4)	The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.35 to $84.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(5)	The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.28 to $84.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(6)	The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.28 to $85.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(7)	Transaction is the exercise of a derivative security; see Column 2.
(8)	Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.